CalciMedica, Inc. - Common Stock (CALC)

CUSIP: 38942Q202

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 6 signals
Share change
-74,858
SEC-reported price per share
$2.86
Indexed holders
10
Value change
-$168,698
Number of buys
4
Number of sells
3
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
7,159,407

Security key

38942Q202

Report period

Q4 2023

Indexed institutions

10

Top holders

8

Ownership snapshot

Top reported holders of CALC - CalciMedica, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Valence Investments SPV I...
Disclosed value leader
Valence Investments SPV I...
Comparable rows
0/15
Latest evidence
30 Sep 2023
3/4/5 13F Highest disclosed value: $2,736,985 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Valence Investments SPV IV LLC has the largest disclosed position value at $2.74M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Valence Investments SPV IV LLC's linked filing trail.
Disclosed position value Top 5
Valence Investments SPV IV LLC $2.74M
ORBIMED ADVISORS LLC $790.9K
Hudson Bay Capital Management LP $432.2K
BML Capital Management, LLC $236.1K
Robert S. Breuil $130.8K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Valence Investments SPV IV LLC
3/4/5
10%+ Owner
—
mixed-class rows
$2,736,985
749,261 shares
mixed-class rows
— 20 Mar 2023
ORBIMED ADVISORS LLC
13F
Company
13F
—
denominator unverified
$790,882
297,380 shares
— 30 Sep 2023
Hudson Bay Capital Management LP
13F
Company
13F
—
denominator unverified
$432,160
166,857 shares
— 30 Sep 2023
BML Capital Management, LLC
13F
Company
13F
—
denominator unverified
$236,113
88,781 shares
— 30 Sep 2023
Robert S. Breuil
3/4/5
Chief Financial Officer
—
denominator unverified
$130,777
35,326 shares
— 23 Mar 2023
Parisa Zamiri
3/4/5
Chief Medical Officer
—
denominator unverified
$107,291
28,982 shares
— 23 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
10
Shares
516,778
Indexed holders
10
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 indexed holders
11
Q4 2023 indexed holders
10
Indexed holder difference
-1
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .